• YAKHAK HOEJI
• /
• v.40 no.4
• /
• pp.442-448
• /
• 1996

Mitomycin C(MMC) has been used as an anticancer drug and behaves as an alkylating agent forming covalent cross-link between complementary strands of double strand DNA. The purpose of this research was to determine number of DNA adducts, formed in vivo by Mitomycin C, in mouse organs. DNAs from liver, lung, brain and pancreas were isolated and used for $^{32}P$-postlabelling. The labeled nucleotides were separated by 2D-TLC and subjected to autoradiography. Numbers of MMC-DNA adducts were 9,9,5,4 in liver, pancreas, lung and brain, respectively.

• 대한생식의학회:학술대회논문집
• /
• 2004.11a
• /
• pp.33-33
• /
• 2004

• Toxicological Research
• /
• v.26 no.1
• /
• pp.53-59
• /
• 2010

This study was conducted to obtain acute information of the oral dose toxicity of DHU001, a polyherbal formula in male and female mice. In order to calculated 50% lethal dose ($LD_{50}$) and approximate lethal dose (LD), test material was once orally administered to male and female ICR mice at dose levels of 2000, 1000, 500, 250 and 0 (vehicle control) ml/kg (body weight). The mortality and changes on body weight, clinical signs, gross observation, organ weight and histopathology of principle organs were monitored 14 days after treatment with DHU001. We could not find any mortalities, DHU001 treatment-related clinical signs, changes on the body and organ weights, gross and histopathological findings. The results obtained in this study suggest that $LD_{50}$ and approximate LD in mice after single oral dose of DHU001 were considered over 2000 mg/kg in both female and male mice.

• Toxicological Research
• /
• v.2 no.1
• /
• pp.23-30
• /
• 1986

Acute toxicity study was conducted on a Hepatitis B vaccine (Hepaccine-B-inj.) with mice, guinea pigs, and rabbits, in accordance with the norms suggested by the F.D.A. in U.S.A. Dose ranges were 2 doses/mouse, 5 doses/guinea pig, 10 doses/rabbit. They received the vaccine subcutaneously and intraperitoneally. Thereafter, all animals injected were observed of general signsdaily, and of body weight for two weeks. At the end of the observation period (or at the time of death), all animals received the highest dose group were autopsied and gross observation was made on various organs and tissues. No significant toxicity was noted.

• The Korean Journal of Zoology
• /
• v.10 no.1
• /
• pp.10-16
• /
• 1967

본 연구는 백서후각기의 발생과정을 세포조직학적으로 규명보고하는 바이며 사용된 stage는 stage 20부터 32까지는 Christe(1964)의것을 인용하였으며 그 외에 명시된 stage 33,34, 35 는 저자가 편의상 구분하였다. 재료는 백서 5 필을 온실서 충분한 영양으로 사육후 임신시켜 요구되는 배를 stage 별로 얻어 Bouin's solution 에 고정시켜 paraffin법을 따랐으며 5-7$\mu$의 두께로 절편을 만들어 Delafield's hematoxylin, eosin, thionin 에 염색하였다. Stage 별 후각기의 발생은 state 20 에 후순, state 22에 후와 및 조비기(Jacobson's organ), stage23A에 구비강막(oro-nasal membrane), state 23 B 에 수신경섬유 와 원시내비공, stage 24 에 조비기신경섬유, stage 27에는 골갑개상피에 후세포와 호흡상피상에 섬유 또한 악골갑개상피에서 seromucinous 선들이 최초로 나타났다. 본 실험결과 백서후각기의 형성과정은 인체와 생쥐( mouse) 에서와 유사하나 조비기의 성장, 비갑개의수, 및 후역의 범위에 있어서는 극히 차가 심한 것같다.

• Proceedings of the Korean Society of Toxicology Conference
• /
• 2002.11b
• /
• pp.169-169
• /
• 2002

The present was performed to identify the effects of tributyltin oxide (TBTO) in the immature mice testes. 3-week-old male ICR mice were orally administrated on one time basis of TBTO dose of 0 (Vehicle control, VC), 30 (TBTO 30 mg/kg, T30), 60 (TBTO 60 mg/kg, T60) per each one.(omitted)

• Biomolecules & Therapeutics
• /
• v.4 no.2
• /
• pp.138-147
• /
• 1996

DWP401, a recombinant human epidermal growth factor, was subcutaneously administered to ICR mice at the dose levels of 0, 0.04, 0.2 and 1.0 mg/kg/day (15rats/sex/group) in order to evaluate the subchronic toxicity. General observations, examinations for food and water consumption, ophthalmoscopy and urinalysis were carried out during the study. For the complete gross and microscopic examinations, 10 mice/ sex/group were sacrificed at the ends of the dosing period, and the remaining animals were sacrificed with a 5 week recovery period. Examinations for hematology and blood biochemistry were also carried out at the time of recovery period. Based on the results, it was thought that the target tissue or organs were mesothelial cell, injection site, spleen, adrenal gland, ovary and transitional epithelial cell of urinary tract, and no observed toxic level of DWP401 was 0.04 mg/kg while definite toxic dose level might be 0.2 mg/kg.

• Biomolecules & Therapeutics
• /
• v.10 no.4
• /
• pp.258-267
• /
• 2002

In this study the general pharmacological profiles of AS6 on the central nervous system, cardiovascular and the other organs were investigated. The dosages given were 0, 250, 500 and 1000 mg/kg and drugs were orally administered. The animals used for this study were mice, rats and guinea pigs. Significant increases (p<0.01) in the charcoal transport capacity were observed at the high dose of 1000 mg/kg and significant increases in retardation of pain threshold were observed in the test using acetic acid in all dosed animals. However, AS6 showed no noticeable effects on general behavior, motor coordination, spontaneous locomotor activity, hexobarbital-induced sleep time, body temperature, analgesic activity in the test using hot plate method and anticonvulsant activity. Furthermore no noticeable effects were observed in cardiovascular functions in the isolated rat heart, contraction and relaxation of the smooth muscle in the isolated guinea ileum, gastric secretion and renal function.

• BMB Reports
• /
• v.54 no.7
• /
• pp.344-355
• /
• 2021

Mucins are high molecular-weight epithelial glycoproteins and are implicated in many physiological processes, including epithelial cell protection, signaling transduction, and tissue homeostasis. Abnormality of mucus expression and structure contributes to biological properties related to human cancer progression. Tumor growth sites induce inhospitable conditions. Many kinds of research suggest that mucins provide a microenvironment to avoid hypoxia, acidic, and other biological conditions that promote cancer progression. Given that the mucus layer captures growth factors or cytokines, we propose that mucin helps to ameliorate inhospitable conditions in tumor-growing sites. Additionally, the composition and structure of mucins enable them to mimic the surface of normal epithelial cells, allowing tumor cells to escape from immune surveillance. Indeed, human cancers such as mucinous carcinoma, show a higher incidence of invasion to adjacent organs and lymph node metastasis than do non-mucinous carcinoma. In this mini-review, we discuss how mucin provides a tumor-friendly environment and contributes to increased cancer malignancy in mucinous carcinoma.

• Journal of Life Science
• /
• v.25 no.12
• /
• pp.1415-1424
• /
• 2015

ICI 182, 780 (ICI) has been used as an estrogen receptor inhibitor in several mammalian species. This study was conducted to observe histological changes in the reproductive system of pubescent male mice following ICI treatment, as well as to investigate the recovery of the organs over time. To accomplish this, ICI at 5 mg/0.1 ml of castor oil was subcutaneously injected into 5-week-old male mice once per week for 4 weeks. The mice were then randomly divided into no-recovery, 150-day recovery, and 300-day recovery groups. The testis of the no-recovery group showed atrophy of the seminiferous tubules, with decreased Sertoli cell numbers and thickness of the germinal epithelium. In the epididymis, the cell height of epithelial tissues was altered, but these changes were not observed in the 300-day recovery group. In the efferent ductule, the luminal diameter was increased, but the cell height of the epithelial tissues was decreased. In the prostate and seminal vesicles, the cell height of the epithelial tissues was increased, and these changes were not observed in the 150-day recovery group. These results show that ICI causes histological changes in pubescent male reproductive organs but that these changes are resolved with time.